CD44 and breast cancer: In breast cancer, the binding of LMW‐hyaluronan with CD44 and TLR2/4 promotes cell invasion, along with the activation of NF‐κB pathway and transcription and release of pro‐inflammatory cytokines such as ΤΝF‐α, IL‐1β, IL‐8, and IL‐12.